Maviret (Glecaprevir-Pibrentasvir)
Maviret (Glecaprevir-Pibrentasvir)
Pibrentasvir Glecaprevir
Product information
MAVIRET treats chronic hepatitis C in adults. It combines glecaprevir and pibrentasvir to eliminate the virus. Take three tablets daily with food. It's effective for HCV genotypes 1-6, with or without cirrhosis. Common side effects include headache and fatigue. Not recommended for patients with moderate or severe liver impairment. Always follow your healthcare provider’s instructions and inform them of any other medications you are taking.
In stock and ready to ship.
Prescription Required • Product of Canada • Shipping from Canada
Product options
SAVE on MAVIRET ordering online from Canada - USA Prescription Required
MAVIRET™ (Glecaprevir/Pibrentasvir) - Canada Product Information
What is MAVIRET?
MAVIRET is a medication used to treat chronic hepatitis C virus (HCV) infection in adults. It contains two antiviral agents, glecaprevir, and pibrentasvir, which work together to eliminate the virus from your body.
Who Should Use MAVIRET?
MAVIRET is prescribed for adult patients with chronic HCV infection. It can be used by patients with or without compensated cirrhosis. It is suitable for patients with HCV genotype 1, 2, 3, 4, 5, or 6.
How to Take MAVIRET
Important Precautions
Possible Side Effects
Common side effects may include:
- Headache
- Fatigue
- Nausea
- Diarrhea
- Itching (pruritus)
If any side effects are severe or persistent, contact your healthcare provider.
Drug Interactions
MAVIRET may interact with other medications. Inform your healthcare provider about all the medicines you take, including over-the-counter drugs, vitamins, and herbal supplements.
Storage Instructions
Store MAVIRET tablets between 36°F and 86°F. Keep the medication in its original packaging until you are ready to take it.
When to Contact Your Doctor
For more detailed information about MAVIRET, including how it works and the scientific data behind it, please consult your healthcare provider or refer to the patient medication information leaflet provided with the medication.
Reference: Maviret Canada product monograph